Bonraybio CoTPE:6955 -0.41%65 PB Ratio is 4.64 as of Jul. 07, 2026, which is 30% below its 10-year median of 6.64. GuruFocus rates TPE:6955 with a GF Score™ of 65/100 and a GF Value™ of NT$184.74 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Bonraybio Co ranks worse than 77.79% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-07), Bonraybio Co's share price is NT$120.00. Bonraybio Co's Book Value per Share for the quarter that ended in Dec. 2025 was NT$25.86. Hence, Bonraybio Co's PB Ratio of today is 4.64.
Good Sign:
Bonraybio Co Ltd stock PB Ratio (=4.66) is close to 3-year low of 4.66.
The historical rank and industry rank for Bonraybio Co's PB Ratio or its related term are showing as below:
TPE:6955'
s PB Ratio Range Over the Past 10 Years
Min: 4.64 Med: 6.64 Max: 9.84
Current: 4.64
During the past 6 years, Bonraybio Co's highest PB Ratio was 9.84. The lowest was 4.64. And the median was 6.64.
TPE:6955's PB Ratio is ranked worse than 77.79% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.05
vs TPE:6955: 4.64
During the past 12 months, Bonraybio Co's average Book Value Per Share Growth Rate was 12.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 32.40% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 37.60% per year.
During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Bonraybio Co was 39.00% per year. The lowest was 30.60% per year. And the median was 32.40% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Bonraybio Co PB Ratio Related Terms
Bonraybio Co PB Ratio Historical Data
* Premium members only.
The historical data trend for Bonraybio Co's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Bonraybio Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bonraybio Co PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bonraybio Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Bonraybio Co's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Bonraybio Co's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Bonraybio Co (TPE:6955) has a PB Ratio of 4.64 as of Jul. 07, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Bonraybio Co and its competitors. This is 30% below median its historical median of 6.64. Over the past decade, Bonraybio Co's PB Ratio has ranged from 4.64 to 9.84. According to the industry distribution chart, Bonraybio Co ranks #613 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 77.8%.
Is Bonraybio Co's PB Ratio too high?
Bonraybio Co's current PB Ratio of 4.64 is 30% below median its 10-year median of 6.64. Over the past 10 years, this metric has ranged from a low of 4.64 to a high of 9.84. The Medical Devices & Instruments industry median PB Ratio is 2.05. Bonraybio Co's value of 4.64 is 126.3% above this industry median. Based on the distribution chart, Bonraybio Co ranks #613 out of 788 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Bonraybio Co has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bonraybio Co's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Bonraybio Co ranks #613 out of 788 companies for PB Ratio. This places Bonraybio Co in the lower half of its industry. The industry median PB Ratio is 2.05. Bonraybio Co's value of 4.64 is 126.3% above this benchmark. Historically, Bonraybio Co's own PB Ratio has ranged from 4.64 to 9.84 over the past decade. While the company's 10-year median is 6.64 vs. the industry median of 2.05, Bonraybio Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.05, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bonraybio Co's current PB Ratio of 4.64 is 126.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Bonraybio Co and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bonraybio Co's current PB Ratio is 4.64, which is 30% below median its own 10-year median of 6.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bonraybio Co stock overvalued right now?
Based on GuruFocus' analysis, Bonraybio Co (TPE:6955) is currently considered Possible Value Trap. The stock's GF Value™ is NT$184.74, compared to a current price of NT$120.00 — trading 35% below its estimated fair value. The current PB Ratio is 4.64, which is 30% below median its 10-year median of 6.64 and 126.3% above the Medical Devices & Instruments industry median of 2.05. Bonraybio Co's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Bonraybio Co (TPE:6955), the current PB Ratio is 4.64 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bonraybio Co (TPE:6955) Overvalued in 2026?
Based on GuruFocus' analysis, Bonraybio Co stock appears to be undervalued.
The current stock price of NT$120.00 is trading 35% below its estimated GF Value™ of NT$184.74.
GuruFocus considers Bonraybio Co to be Possible Value Trap.
Key valuation signals for TPE:6955:
PB Ratio: 4.64 (30% below median its 10-year median of 6.64)
GF Value™: NT$184.74 vs. price of NT$120.00 (35% below fair value)
Industry Position: 126.3% above the Medical Devices & Instruments median (#613 of 788)
No single metric tells the full story. See the TPE:6955 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bonraybio Co Ltd engages in research, development, and manufacturing of vitro diagnostic devices. The firm produces semen quality analyzers and Semen Analysis Systems for the clinic.
65GF Score
Get the complete analysis for TPE:6955
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6955 has been successfully added to your 
